Compass Therapeutics
CMPX
CMPX
92 hedge funds and large institutions have $147M invested in Compass Therapeutics in 2024 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 17 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
6.68% more ownership
Funds ownership: 67% → 73.68% (+6.7%)
13% less capital invested
Capital invested by funds: $170M → $147M (-$22.6M)
Holders
92
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$5.93M | |
| 2 | +$4.24M | |
| 3 | +$631K | |
| 4 |
SG Americas Securities
New York
|
+$517K |
| 5 |
JPMorgan Chase & Co
New York
|
+$330K |
Top Sellers
| 1 | -$7.45M | |
| 2 | -$3.36M | |
| 3 | -$197K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$159K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$121K |